ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,105.94
      -0.20%
      US Tech 100
      17,264.80
      -0.26%
      Dow Jones
      38,156.28
      -0.60%
      Brent Oil
      85.805
      -1.70%
      Bitcoin
      60,709.99
      -4.90%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axogen Inc (AXGN)

      7. Axogen Inc (AXGN) News

      AXGN

      Axogen (AXGN)

      Axogen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXGN
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      04/29/20244:50PMGlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
      04/16/20247:00AMGlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
      03/08/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      03/08/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      03/08/20244:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
      03/07/20246:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
      03/07/20244:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
      03/06/20248:59AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
      03/06/20248:53AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AXGNAxogen Inc
      03/06/20248:45AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AXGNAxogen Inc
      03/05/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      03/05/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
      03/05/20247:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
      03/05/20247:00AMGlobeNewswire Inc.Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
      02/23/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      02/23/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      02/23/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      02/14/20243:22PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
      02/13/20244:30PMGlobeNewswire Inc.Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024NASDAQ:AXGNAxogen Inc
      02/12/20241:21PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXGNAxogen Inc
      02/06/20245:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
      02/02/20244:15PMGlobeNewswire Inc.Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
      02/02/20249:29AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
      01/26/202411:49AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
      01/18/20245:00PMGlobeNewswire Inc.Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve CapNASDAQ:AXGNAxogen Inc
      01/11/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      01/11/20245:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      01/11/20245:07PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
      01/08/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
       Showing the most relevant articles for your search:NASDAQ:AXGN